David Birnie, MD
Ottawa Heart Institute Research Corporation
5
5
1
N/A
0
10
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Pablo B. Nery, MD
Ottawa Heart Institute Research Corporation
Shared therapeutic areas:
Worked with same sponsors:
Pablo Nery, MD
Ottawa Heart Institute Research Corporation
Shared therapeutic areas:
Worked with same sponsors:
Jeff Healey, MD
McMaster University
Shared therapeutic areas:
Worked with same sponsors:
Vidal Essebag, MD
McGill University
Shared therapeutic areas:
Worked with same sponsors:
Rob Beanlands, MD
Ottawa Heart Institute Research Corporation
Shared therapeutic areas:
Worked with same sponsors:
Andy Tran, MD
Scottsdale Healthcare Research Institute
Shared therapeutic areas:
catherine GEINDRE
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Abdi Rasekh, MD
Texas Heart Institute at St. Luke's Episcopal Hospital
Shared therapeutic areas:
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Meral Boşnak Güçlü, PhD
Gazi University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
QOL Improvement After Cardioversion of Persistent AF (QOL-CAFRCT)
Cardiac Sarcoidosis Multi-Center Prospective Cohort
Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial
Cardiac Sarcoidosis Response To Steroids Trial
Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
All 5 trials loaded